🇺🇸 FDA
Patent

US 10022352

Modulators of ATP-binding cassette transporters

granted A61KA61K31/404A61K31/4045

Quick answer

US patent 10022352 (Modulators of ATP-binding cassette transporters) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/404, A61K31/4045, A61K31/405, A61K31/407